EGFR and lung carcinoma: Afatinib-induced tumour shrinkage was also observed in transgenic mice with inducible expression of the oncogenic EGFR L858R mutant in lung epithelium (Regales et al. 2009); within days, afatinib reduced lung cancer size by more than 80 % as assessed by imaging studies.